Tag archive for ‘diabetes treatment developer’
health
Koby Yeshayahou On Wednesday, February 26th, 2014

Clal Biotech Selling Diabetes Treatment Co Andromeda

– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for an immediate More...

Wordpress site Developed by Fixing WordPress Problems